Kelda Group Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:Kelda Group Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C9726
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:環境
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Kelda Group Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Kelda Group Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Kelda Group Ltd (Kelda) is a water utility company engaged in collection, treatment and distribution of water and waste water services. The company offers water and sewerage services in the Yorkshire region through its subsidiary Yorkshire Water; and conducts non-regulated water and waste water contract operations through Kelda Water Services. Kelda also offers customer service support to Yorkshire Water. The company primarily operates in the UK. It is headquartered in Bradford, the UK.

Scope

- Detailed information on Kelda Group Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Kelda Group Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Kelda Group Ltd including a breakdown and examination of key business segments
- Intelligence on Kelda Group Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Kelda Group Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Kelda Group Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Kelda Group Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Kelda Group Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Kelda Group Ltd: Company Overview 8
Kelda Group Ltd: Overview and Key Facts 8
Kelda Group Ltd: Overview 8
Kelda Group Ltd: Key Facts 8
Kelda Group Ltd: Key Employees 9
Kelda Group Ltd: Key Employee Biographies 10
Kelda Group Ltd: Major Products and Services 11
Kelda Group Ltd: Company History 12
Kelda Group Ltd: Management Statement 14
Kelda Group Ltd: Locations and Subsidiaries 16
Kelda Group Ltd: Key Competitors 17
Kelda Group Ltd: Company Analysis 18
Kelda Group Ltd: Business Description 18
Kelda Group Ltd: SWOT Analysis 19
Kelda Group Ltd: SWOT Overview 19
Kelda Group Ltd: Strengths 19
Kelda Group Ltd: Weaknesses 20
Kelda Group Ltd: Opportunities 20
Kelda Group Ltd: Threats 21
Kelda Group Ltd: Corporate Financial Deals Activity 23
Kelda Group Ltd: Financial Deals Overview 23
Kelda Group Ltd: Targets and Partners 25
Kelda Group Ltd: Top Deals 2014 – 2018YTD* 26
Kelda Group Ltd: Mergers and Acquisitions 27
Kelda Group Ltd: Divestments 28
Kelda Group Ltd: Recent Developments 29
Kelda Group Ltd: News and Events Summary 29
Kelda Group Ltd: Contracts 33
Kelda Group Ltd: Corporate Governance 34
Kelda Group Ltd: Financial Performance 34
Kelda Group Ltd: Strategy and Operations 34
Appendix 37
Contact Us 37
Methodology 37
About MarketLine 38

List of Tables
Table 1: Kelda Group Ltd: Key Facts
Table 2: Kelda Group Ltd: Key Employees
Table 3: Kelda Group Ltd: Company History
Table 4: Kelda Group Ltd: Locations and Subsidiaries
Table 5: Kelda Group Ltd: Key Competitors
Table 6: Kelda Group Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Kelda Group Ltd: M&A Activity by Geography (TTM*)
Table 8: Kelda Group Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Kelda Group Ltd: Targets and Partners
Table 10: Kelda Group Ltd: Top Deals 2014 - 2018YTD*
Table 11: Kelda Group Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Kelda Group Ltd: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Kelda Group Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Kelda Group Ltd: Divestments by Geography (2014 - YTD*2018)
Table 15: Kelda Group Ltd: News and Events Summary
Table 16: Kelda Group Ltd: Contracts
Table 17: Kelda Group Ltd: Corporate Governance
Table 18: Kelda Group Ltd: Financial Performance
Table 19: Kelda Group Ltd: Strategy and Operations

List of Figures
Figure 1: Kelda Group Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Kelda Group Ltd: M&A Activity by Geography (TTM*)
Figure 3: Kelda Group Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Kelda Group Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Kelda Group Ltd: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Kelda Group Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 7: Kelda Group Ltd: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Kelda Group Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Riemser Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products provider that markets and sells lifecycle management products. The company offers analgesics, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. Its products inc …
  • Matica Technologies AG:企業の戦略的SWOT分析
    Matica Technologies AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The Carlyle Group LP (CG):企業の財務・戦略的SWOT分析
    The Carlyle Group LP (CG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Knoll, Inc.:企業の戦略・SWOT・財務情報
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析
    Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Actinium Pharmaceuticals Inc (ATNM):製薬・医療:M&Aディール及び事業提携情報
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lincoln Pharmaceuticals Ltd (Lincoln Pharmaceuticals) manufactures, markets and exports pharmaceutical products. The company provides pharmaceuticals for cardiovascular, central nervous system, dermatology and ear nose throat disorders; gastrointestinal and genitourinary infections; hematolo …
  • Lycored Ltd:企業の戦略・SWOT・財務情報
    Lycored Ltd - Strategy, SWOT and Corporate Finance Report Summary Lycored Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MAXrad SOFTware (India) Pvt. Ltd.:企業の戦略・SWOT・財務情報
    MAXrad SOFTware (India) Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MAXrad SOFTware (India) Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sernova Corp (SVA):医療機器:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • PGE Polska Grupa Energetyczna SA (PGE):企業の財務・戦略的SWOT分析
    PGE Polska Grupa Energetyczna SA (PGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • FirstString Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary FirstString Research Inc (FirstString) is a biopharmaceutical company that discovers and develops therapies for inflammation and injury based medical conditions. The company markets new therapeutic products that enable physicians to treat unmet medical need. It offers therapeutic approach, w …
  • Astellas Pharma Inc (4503):医療機器:M&Aディール及び事業提携情報
    Summary Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company’s product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, inf …
  • Ferndale Pharma Group Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferndale Pharma Group Inc (Ferndale Pharma), formerly Ferndale Laboratories Inc is a manufacturer and distributor of pharmaceutical products. The company provides surgical instruments, medical supplies, skin care products, topical therapeutic products, prescription, over the counter products …
  • AFFiRiS AG-製薬・医療分野:企業M&A・提携分析
    Summary Affiris AG (AFFiRiS) is a drug development company that develops and manufactures novel synthetic vaccines against chronic diseases. The company develops customized peptide vaccines based on its proprietary affitome technology for the prevention of Alzheimer's disease, Parkinson's disease, a …
  • Tampa Electric Co:企業の発電所・SWOT分析2018
    Tampa Electric Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Arriva plc:企業の戦略・SWOT・財務情報
    Arriva plc - Strategy, SWOT and Corporate Finance Report Summary Arriva plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Dunavant Enterprises, Inc.
    Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Elders Limited:企業の戦略・SWOT・財務情報
    Elders Limited - Strategy, SWOT and Corporate Finance Report Summary Elders Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Boryung Pharmaceutical Co Ltd (003850):企業の財務・戦略的SWOT分析
    Summary Boryung Pharmaceutical Co Ltd (Boryung), formerly Boryung Drugs Co Ltd is a pharmaceutical company that develops drugs for the treatment of cancer, infections and gene therapy, besides vaccines, other biopharmaceuticals and new chemical entities (NCE). The company provides major products suc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆